According to Entrada Therapeutics's latest financial reports the company's current earnings (TTM) are S$0.12 B. In 2023 the company made an earning of -S$4.12 M an increase over its 2022 earnings that were of -S$0.13 B.The earnings displayed on this page is the company's Pretax Income.